News summary

Oyster surfaces with $60m and a tau degrader that travels light

Source: Longevity Technology • Published: 10 Nov 2026, 16:02

Summarized by Masters of Longevity from Longevity Technology.

London startup rebrands and secures $60 million while unveiling a compact tau degrader approach.

Oyster surfaces with $60m and a tau degrader that travels light
Key Takeaways
  • Bifunctional degraders are often too large for the blood–brain barrier.
  • Oyster has raised $60 million to develop tau degrader delivery.
  • Smaller degraders and transport tactics may enable brain targeting.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.